COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Wisconsin patients with a documented clinical need may be eligible for compounded tirzepatide.
Wisconsin's healthcare network spans Milwaukee, Madison, and Green Bay, but northern and western counties may have fewer local options. Compounding Finder helps Wisconsin patients compare licensed pharmacies statewide.
Yes. The Wisconsin Pharmacy Examining Board oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.